Panic Disorder Neurobiological and Treatment Aspects
The book focuses on the neurobiological and treatment aspects of panic disorder. It describes the most recent research data and pharmacological therapeutic aspects of panic disorder. The biochemical, respiratory, imaging, and translational
- PDF / 7,598,227 Bytes
- 323 Pages / 496.12 x 737.01 pts Page_size
- 105 Downloads / 217 Views
Panic Disorder Neurobiological and Treatment Aspects
123
Panic Disorder
Antonio Egidio Nardi Rafael Christophe R. Freire Editors
Panic Disorder Neurobiological and Treatment Aspects
Editors Antonio Egidio Nardi Laboratory of Panic and Respiration, Institute of Psychiatry Federal University of Rio de Janeiro Rio de Janeiro, Brazil
Rafael Christophe R. Freire Laboratory of Panic and Respiration, Institute of Psychiatry Federal University of Rio de Janeiro Rio de Janeiro, Brazil
ISBN 978-3-319-12537-4 ISBN 978-3-319-12538-1 DOI 10.1007/978-3-319-12538-1
(eBook)
Library of Congress Control Number: 2016939239 © Springer International Publishing Switzerland 2016 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer International Publishing AG Switzerland
To Andrea A.E.N. To Ana Catarina R.C.R.F.
Foreword
Needless to say, I am immensely gratified to be asked to write the foreword to this volume, which exemplifies the multiple, burgeoning approaches to the understanding of panic. Your editors’ historical approach refers to ancient descriptions of the panic attack and the various attempts to develop an understanding of anxiety related conditions. They state that, “In 1954, Mayer-Gross associated anxiety disorders to hereditary, organic and psychological factors, dividing them in simple anxious states and phobic anxious states. In 1959, Donald Klein observed that patients with these disorders responded favorably to imipramine, a tricyclic antidepressant.” Naturally, the protagonist of this event has a more detailed and complicated recollection. Our concern in the late 1950s was to understand the effects of this new agent, imipramine. European studies stated it to be an antidepressant, so our expectation was that it would be a super cocaine and blow the patients out of their rut. At Hillside Hospital, a psychoanalytic hospital, the premium treatment was psychoa
Data Loading...
